Enregistrement :
13
de
14
(2022-11-11
à
2024-05-03)
Politique ou Programme
Engagement with officials on issues related to rare disorder and orphan drug policies in the context of the development of national pharmacare.
Establish Health Canada policies or programs related to orphan drug policy to address treatment for rare disorders, including part of any national pharmacare program or strategy
Establish Health Canada policies to ensure access to essential treatment for rare disorders
Establish Innovation, Science and Economic Development Canada policies related to research and development of treatments for rare disorders
Scientific Research and Experimental Development Tax Incentive Program as it pertains to research and development of treatments for rare disorders
Politique ou Programme, Règlement
Share perspectives of the rare disorders patient community on drug pricing issues, specifically regulations and guidelines related to the Patented Medicine Prices Review Board.
Règlement
Regulatory amendments to the Food and Drugs Act Regulations to implement an orphan drug regulatory framework.